Russian COVID vaccine: why more and more countries are turning to Sputnik V

By Sarah Schiffling, Senior Lecturer in Supply Chain Management, Liverpool John Moores University
Liz Breen, Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford

When the Russian president, Vladimir Putin, announced on August 11 2020 that the country’s health regulator had become the first in the world to approve a COVID-19 vaccine for widespread use, the news was greeted with scepticism. No trials had been completed on the vaccine’s safety and efficacy.

While the initial reception of Sputnik V was critical, in February 2021, preliminary results of the phase 3 trials were reported with a 91.6%…

Read complete article

~	Tanzania’s new VPN policy leaves LGBTQ+ individuals exposed

~	Why do metaphors of space help us understand time?

~	Cycling: The untapped potential for improving our health (and the climate)

~	We need to talk about Chinese and US influence in Europe’s energy industry

~	What if companies rewarded employees for their failures?

~	‘Eye watering’ spending, growing debt make up surprisingly generous Victorian state budget

~	If the RBA’s right, interest rates may not fall for another year. Here’s why – and what it means for next week’s budget

~	Coalition demands amendments to government’s deportation bill, as crucial High Court judgement set for Friday

~	Expelling students for bad behaviour seems like the obvious solution, but is it really a good idea?

~	A story of trauma, hope and regaining control, Nayika: A Dancing Girl is soul-stirring dance theatre